Sivia Capital Partners’s Boston Scientific BSX Stock Holding History

Sivia Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,843	Closed	-$1.68M	–	552
2026 Q1	$1.68M	Buy	26,843 +22,797	+563%	+$1.82M	0.33%	64
2025 Q4	$386K	Sell	4,046 -734	-15%	-$72K	0.08%	334
2025 Q3	$467K	Buy	4,780 +432	+10%	+$44.7K	0.13%	190
2025 Q2	$467K	Sell	4,348 -76	-2%	-$7.69K	0.16%	140
2025 Q1	$446K	Buy	4,424 +632	+17%	+$63.6K	0.21%	81
2024 Q4	$339K	Sell	3,792 -26	-0.7%	-$2.29K	0.17%	100
2024 Q3	$320K	Sell	3,818 -7	-0.2%	-$552	0.19%	115
2024 Q2	$295K	Buy	3,825 +151	+4%	+$11.1K	0.2%	111
2024 Q1	$252K	Hold	3,674	–	–	0.17%	139
2023 Q4	$212K	Buy	+3,674	New	+$196K	0.16%	156

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sivia Capital Partners's BSX Position: Q2 2026 in Review

Sivia Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 26,843 shares — an estimated $1.68M sold.

Sivia Capital Partners first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $1.68M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sivia Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Sivia Capital Partners sold 26,843 Boston Scientific shares in Q2 2026, an estimated $1.68M.
Sivia Capital Partners first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Sivia Capital Partners's Boston Scientific position peaked at $1.68M in Q1 2026.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.